Introduction
============

Obesity and associated metabolic disorders (e.g., insulin resistance, type 2 diabetes, and cardiovascular diseases) are closely associated with a low-grade inflammatory state (Olefsky and Glass, [@B52]). Numerous studies have proposed that, in obese conditions, both the endocrine activity of adipose tissue and macrophage infiltration participate in the development of a low-grade inflammatory tone (Olefsky and Glass, [@B52]). Compelling evidence supports the idea that adipokines participate in the regulation of glucose homeostasis and low-grade inflammation (Deng and Scherer, [@B15]; Federico et al., [@B26]). Among the recently discovered adipokines, apelin has been proposed as a novel key peptide involved in the regulation of several physiological functions. Apelin and APJ mRNA are widely expressed in mammals and exert functional effects in both the central nervous system and the periphery (Sorli et al., [@B56]). Apelin plays a key role in the cardiovascular system by acting on heart contractility, blood pressure, fluid homeostasis, vessel formation, and cell proliferation (Maenhaut and Van, [@B42]). Apelin serum levels are linked to the nutritional status and plasma insulin levels in both rodents and humans (Dray et al., [@B20]; Duparc et al., [@B21]). Furthermore, apelin plasma concentrations are increased in obese subjects and in hyperinsulinemic obese mice compared to lean subjects (Dray et al., [@B19]). Interestingly, apelin has been shown to control glucose homeostasis by AMP-kinase- and nitric oxide (NO)-dependent mechanisms (Dray et al., [@B20]; Duparc et al., [@B22]). Recently, it has been proposed that inflammation could participate in the production of apelin and the modulation of its receptor expression (Daviaud et al., [@B13]; Han et al., [@B28],[@B29]). Nevertheless, the mechanisms involved in the regulation of apelin and its specific G protein-coupled receptor APJ have not been completely elucidated.

Growing evidence supports the role of gut microbiota in the development of obesity, type 2 diabetes, insulin resistance, and low-grade inflammation (Backhed et al., [@B1]; Ley et al., [@B39]; Turnbaugh et al., [@B59]; Cani et al., [@B4], [@B6], [@B8]; Martinez et al., [@B44]; Vijay-Kumar et al., [@B62]). However, the composition of the gut microbiota and the exact role of the microorganisms present in the gut remain poorly defined. Nonetheless, advances in culture-independent methods for characterizing microbial diversity have helped to evaluate the functional contribution of this large collection of microbes in host metabolism (Martin et al., [@B43]; Turnbaugh et al., [@B60]). For instance, recent data suggest that changes in gut microbiota composition and gut barrier functions play a critical role in the development of obesity-associated inflammation (Brun et al., [@B3]; Cani et al., [@B6], [@B8]; De La Serre et al., [@B14]). Accordingly, we have proposed that obesity-associated low-grade inflammation and adipogenesis processes may be related to the gut microbiota by mechanisms involving the endocannabinoid system (eCB) and bacterially derived lipopolysaccharide (LPS; Cani et al., [@B4],[@B5], [@B6], [@B8]; De La Serre et al., [@B14]; Muccioli et al., [@B50]).

The eCB system is composed of endogenous lipids that activate specific G protein-coupled receptors termed cannabinoid receptors 1 and 2 (CB~1~ and CB~2~). Among these lipids, *N*-arachidonoylethanolamine (anandamide, AEA), and 2-arachidonoylglycerol (2-AG) are the most studied (Lambert and Muccioli, [@B36]). AEA and 2-AG are both widely present throughout the body, and their tissue levels are regulated by the balance between synthesis and inactivation. Briefly, *N*-acylphosphatidylethanolamines (NAPEs) are precursors for AEA through the activity of *N*-acylphosphatidylethanolamine-selective phospholipase-D (NAPE-PLD), whereas 2-AG can be synthesized mainly through diacylglycerol lipase (DAGL; Muccioli, [@B49]). Compelling strong evidence has shown that dysregulation of the tight control of endocannabinoid levels may result in pathological situations such as obesity and related metabolic syndromes or neurological disorders (Lambert and Muccioli, [@B36]). The main enzymes responsible for their degradation are fatty acid amide hydrolase (FAAH; Cravatt et al., [@B12]) and monoacylglycerol lipase (MGL; Dinh et al., [@B18]), respectively. Obesity and type 2 diabetes are associated with greater eCB system tone (altered expression of NAPE-PLD, CB~1~ mRNA, and higher eCB levels in plasma or adipose tissue; Muccioli et al., [@B50]). Moreover, LPS is known to stimulate eCB synthesis (Liu et al., [@B40]; Muccioli et al., [@B50]), and the gut microbiota participate in this complex regulation (Muccioli et al., [@B50]).

Although changes in the gut microbiota of obese mice (*ob*/*ob*) or mice with high-fat diet-induced obesity were clearly demonstrated (Ley et al., [@B38]; Cani et al., [@B4],[@B5]; Turnbaugh et al., [@B58], [@B60]; Hildebrandt et al., [@B32]), the exact composition of the gut microbiota of type 2 diabetic mice (*db*/*db*) remains unknown. In light of these recent findings, we also decided to investigate the potential implication of these three key players (eCB, LPS, and the gut microbiota) in the regulation of apelin and APJ expression in adipose tissue. Therefore, we combined multiple molecular methods, including bar-coded pyrosequencing and phylogenetic microarray analysis of 16S ribosomal RNA (rRNA) genes, to compare the gut microbial communities in genetic obese and diabetic mice with their lean littermates. The data presented herein demonstrated that apelin and APJ expression were down-regulated by the eCB in physiological conditions and were up-regulated by the bacteria-derived compound LPS in pathological situations. In addition, gut microbiota profiling revealed specific relationships between the gut microbiota and regulation of the apelinergic system and also potential novel bacterial targets that are essential to the host metabolism.

Materials and Methods
=====================

Mice
----

Six-week-old *db*/*db* mice or lean littermates (*n* = 6/group; C57BL/6 background, Jackson-Laboratory, Bar Harbor, ME, USA) were housed in a controlled environment (12-h daylight cycle, lights-off at 6-pm) in groups of two mice/cage. Both groups of mice were given free access to similar control diet (A04, Villemoisson sur Orge, France) and tap water for 1 week.

All mouse experiments were approved by and performed in accordance with the guidelines of the local ethics committee. Housing conditions were specified by the Belgian Law of November 14, 1993, regarding the protection of laboratory animals (agreement number LA1230314).

Tissue sampling
---------------

Seven-week-old mice were anesthetized by intraperitoneal injection of 100 mg/kg ketamine and 10 mg/kg xylazine after a 5-h fasting period. Blood samples were harvested for further analysis. Mice were sacrificed by cervical dislocation. Subcutaneous adipose deposits were dissected and immediately immersed in liquid nitrogen and stored at −80°C for further analysis.

Plasma apelin
-------------

Apelin was measured using an Apelin EIA kit (Phoenix peptides) according to the manufacturer's instructions.

Measurement of anandamide (AEA) tissue levels
---------------------------------------------

Tissues were homogenized in CHCl~3~ (10 ml), and a deuterated standard (d-AEA; 200 pmol) was added. Methanol (5 ml) and H~2~O (2.5 ml) were added, and lipids were then extracted by vigorous mixing. Following centrifugation, the organic layer was recovered, dried under a stream of N~2~ and purified by solid-phase extraction using silica, followed by elution with an EtOAc--Acetone (1:1) solution (Muccioli and Stella, [@B51]; Muccioli et al., [@B50]). The resulting lipid fraction was analyzed by HPLC--MS using an LTQ Orbitrap mass spectrometer (Thermo Fisher Scientific) coupled to an Accela HPLC system (Thermo Fisher Scientific). Analyte separation was achieved using a C-18 Supelguard pre-column and a Supelcosil LC-18 column (3 μM, 4 × 150 mm; Sigma-Aldrich). Mobile phases A and B were composed of MeOH--H~2~O--acetic acid 75:25:0.1 (v/v/v) and MeOH--acetic acid 100:0.1 (v/v), respectively. The gradient (0.5 ml/min) was designed as follows: transition from 100% A to 100% B linearly over 15 min, followed by 10 min at 100% B and subsequent re-equilibration at 100% A. We performed MS analysis in the positive mode with an APCI ionization source. The capillary and APCI vaporizer temperatures were set at 250 and 400°C, respectively. Anandamide was quantified by isotope dilution using its respective deuterated standard with identical retention. The calibration curves were generated as previously described (Muccioli and Stella, [@B51]), and the data were normalized by tissue sample weight.

DNA isolation from mouse cecal samples
--------------------------------------

The cecal contents of mice collected *post mortem* were stored at −80°C. Metagenomic DNA was extracted from the cecal contents (five *db*/*db* and five lean) using a QIAamp DNA Stool Mini kit (Qiagen, Hilden, Germany) according to the manufacturer's instructions. Two cecal contents were not included in further gut microbiota analyses for technical reasons.

16S rRNA gene amplification and sequencing
------------------------------------------

For each sample, we amplified the V1--3 region of the bacterial 16S rRNA gene corresponding to *Escherichia coli* 16S rRNA gene positions 28--514, excluding primer sequences. PCRs included 1 μl of 50× diluted purified DNA, 0.5 μM of forward B-8fhomd (5′-gccttgccagcccgctcag-*ac*-GAGTTTGATCMTGGCTCA G-3′), 0.05 μM of forward B-8f-Bifido (5′-gccttgccagcccgctcag-*ac*-AGGGTTCGATTCTGGCTCAG-3′), and 0.5 μM of a bar-coded reverse A-534RhomdDEGa primer (5′-gcctccctcgcgccatcag-NNNNNNNN-*at*-CCGCGGCTGCTGGCAC-3′) in 50 μl of PrimeStar HS Premix (Takara). These primers included (i) the 454 Life Science 19-base adaptors A (lowercase underlined) or B (lowercase plain); (ii) an eight-base sample-specific barcode sequence (NNNNNNNN; designated 692--701 in Hamady et al. ([@B27]); Table [A1](#TA1){ref-type="table"}); (iii) the sequence of the broad-range 16S forward or reverse primer (uppercase); and (iv) a dinucleotide sequence (lowercase italic) introduced between the 16S primer and the barcode sequence designed to prevent pairing of different barcodes with rDNA targets.

PCRs were performed for 29 cycles at 98°C for 10 s, 56°C for 15 s, and 72°C for 1 min. One microliter of the sample was run on the Agilent 2100 Bioanalyzer using a DNA1000 lab chip to confirm the proper size. Two replicate reactions were pooled and cleaned using the QIAquick PCR purification kit (Qiagen). DNA concentration was assessed using a NanoDrop 1000 spectrophotometer. One hundred nanograms of each of the purified samples were pooled and sequenced on a Genome Sequencer FLX system (Roche).

Bar-coded 16S rDNA amplicons associated with several unrelated projects were included in the same sequencing run. A total of 39,548 reads, which had a quality score \<20, corresponded to *cecal* samples from the 10 mice presented in this study.

Informatic analysis
-------------------

Sequences containing uncalled bases, incorrect primer sequences or runs of ≥10 identical nucleotides were removed. Reads with the 16S rDNA forward oligonucleotide sequence CCGCGRCTGCTGGCGC, containing G instead of A at the penultimate position of the 3′ end, were likely due to a primer synthesis or sequencing artifact (Lazarevic et al., [@B37]) and were not removed from the dataset provided other quality criteria were met. After trimming primer sequences, reads \<200 or \>290 nt and those that incompletely covered the *E. coli* 16S rRNA gene positions 288--514, determined using the RDP pyrosequencing tool Aligner (Cole et al., [@B10]), were discarded, leaving 31,577 sequences. Sequences were examined for potential chimeras using the MG-RAST server (Meyer et al., [@B47]).

Sequences were assigned to representative phylotypes at 97% identity (97%-ID phylotypes) using CD-HIT (Huang et al., [@B33]). Distances between 97%-ID phylotypes aligned by MUSCLE (Edgar, [@B23]) were calculated using FastTree (Price et al., [@B53]). Hierarchical clustering and principal coordinates analyses were performed using UniFrac (Lozupone et al., [@B41]). The taxonomic composition was assigned using the RDP Classifier (Wang et al., [@B63]) with a recommended 50% confidence cut-off. The sequences (31,577 reads) are publicly available at the MG-RAST repository (Meyer et al., [@B47]) under ID 4455129.

MITChip: PCR primers and conditions
-----------------------------------

The Mouse Intestinal Tract Chip (MITChip) is a phylogenetic microarray consisting of 3,580 different oligonucleotides specific for the mouse intestinal microbiota (Derrien et al., in preparation). Both the design and analysis of the MITChip were performed as previously described for the human counterpart (Rajilic-Stojanovic et al., [@B54]). In short, 20 ng of cecal DNA extract was used to amplify the 16S rRNA genes with the primers *T7prom*-Bact-27-for (5′-T GAATTGTAATACGACTCACTATAGGGgtttgatcctggctcag-3′) and Uni-1492-rev (5′-CGGCTACCTTGTTACGAC-3′). Subsequently, an *in vitro* transcription and labeling with Cy3 and Cy5 dyes was performed. Fragmentation of Cy3/Cy5-labeled target mixes was followed by hybridization on the arrays at 62.5°C for 16 h in a rotation oven (Agilent Technologies, Amstelveen, The Netherlands). The slides were washed and dried before scanning. Signal intensity data were obtained from the microarray images using Agilent Feature Extraction software, version 9.1[^1^](#fn1){ref-type="fn"}. Microarray data normalization and further analysis were performed using a set of R-based scripts[^2^](#fn2){ref-type="fn"} in combination with a custom-designed relational database12, which operates under the MySQL database management system[^3^](#fn3){ref-type="fn"}.

RNA preparation and real-time qPCR analysis
-------------------------------------------

Total RNA was prepared from tissues using TriPure reagent (Roche). Quantitation and integrity analysis of total RNA was performed by running 1 μl of each sample on an Agilent 2100 Bioanalyzer (Agilent RNA 6000 Nano Kit, Agilent). cDNA was prepared by reverse transcription of 1 μg total RNA using a Reverse Transcription System kit (Promega, Leiden, The Netherlands). Real-time PCRs were performed with the StepOnePlus^™^ real-time PCR system and software (Applied Biosystems, Den Ijssel, The Netherlands) using Mesa Fast qPCR^™^ (Eurogentec, Seraing, Belgium) for detection according to the manufacturer's instructions. RPL-19 RNA was chosen as the housekeeping gene. Primer sequences for RPL-19, IL-1, F4-80, CD68, MCP-1, TNF-α, Apelin, APJ, CB1, MGL, FAAH, and NAPE-PLD were previously described (Cani et al., [@B6], [@B8]; Dray et al., [@B20]; Muccioli, [@B49]). The primer sequences for CD11c were F-ACG-TCA-GTA-CAA-GGA-GAT-GTT-GGA and R-ATC-CTA-TTG-CAG-AAT-GCT-TCT-TTA-CC. All samples were run in duplicate in a single 96-well reaction plate, and data were analyzed according to the 2^−ΔCT^ method. The identity and purity of the amplified product was checked through analysis of the melting curve carried out at the end of amplification.

Adipose tissue explant cultures
-------------------------------

Subcutaneous adipose depots from 10 C57BL/6J (wild-type lean) mice were precisely dissected, and all visible vessels, particles, and conjunctive tissue were removed. The fat tissue was then cut with scissors into small pieces (4 mm^3^), pooled, and placed in Krebs buffer (pH 7.4) containing 2% (w/v) fatty acid-free BSA, penicillin (100 IU/ml), streptomycin (100 μg/ml), and amphotericin B (2.5 μl/ml; Invitrogen). A total of 250 mg of adipose tissue was rinsed in phosphate-buffered saline and incubated in 100-mm Petri dishes containing 10 ml MEM with Earle's salts (Invitrogen) supplemented with 0.5% fatty acid-free BSA, penicillin (100 IU/ml), streptomycin (100 μg/ml), and amphotericin B (2.5 μl/ml; Invitrogen). All conditions were repeated in four to five different dishes (*n* = 4--5). The dishes were cultured for 24 h at 37°C in a 5% CO~2~ atmosphere. The basal concentration of glucose in fresh media was 5 mmol/l, whereas the basal levels of cortisol and insulin were extremely low (∼0.5 nmol/l and 3 pmol/l, respectively). Different pharmacological agents were used in various combinations in accordance with the experimental protocols. LPS (*E. coli* 055:B5, 100 ng/ml, Sigma) and HU-210 (100 nM, Tocris) were diluted in DMSO, which also served as a control. Cell viability did not change over the course of the experiment (data not shown). At the end of the experiment, the adipose material was rinsed in phosphate-buffered saline, collected, immediately frozen in liquid nitrogen, and stored at −80°C until subsequent mRNA analysis.

Statistical analyses
--------------------

The data are expressed as the mean ± SEM. Differences between two groups were assessed using an unpaired, two-tailed Student's *t*-test. Statistical comparisons of bacterial communities were performed using a two-tailed Student's *t-*test, treating variances as equivalent. Correlations were analyzed using Pearson's correlation. Data were analyzed using GraphPad Prism version 5.00 for Windows (GraphPad Software, San Diego, CA, USA) and JMP 8.0.1 (SAS Campus Drive, Cary, NC, USA). The results were considered statistically significant at *P* \< 0.05.

Results
=======

16S rRNA analysis of gut bacterial populations in obese and diabetic mice compared to lean mice
-----------------------------------------------------------------------------------------------

Obese (*ob*/*ob*) mice and diet-induced obese mice are characterized by an altered composition of the gut microbiota (Ley et al., [@B38]; Cani et al., [@B4],[@B5]; Turnbaugh et al., [@B58], [@B60]). To date, the composition of the gut microbiota of leptin-resistant obese and type 2 diabetic (*db*/*db*) mice has never been reported. The main differences between *ob*/*ob* and *db*/*db* mice are, first, in the leptin system, *ob*/*ob* mice are leptin-deficient (they lack the *ob* gene), whereas *db*/*db* mice are leptin-resistant (the CNS has altered their "leptin receptors"), and, second, by phenotype, both mice are hyperphagic, severely obese and have developed fatty livers. However, *db*/*db* mice become type 2 diabetic early after birth (a few weeks). This major difference between the two models confers to *db*/*db* mice a clear advantage for investigating the role of the gut microbiota in this phenotype. The exact composition of the gut microbiota in this model of obesity and diabetes remains unknown. Therefore, we characterized the gut microbiota composition of obese and diabetic *db*/*db* mice by two complementary approaches: pyrosequencing and phylogenetic microarray analysis of the 16S rRNA genes isolated from mouse cecal samples.

To explore bacterial diversity in cecal samples, we targeted the 16S rDNA hypervariable region V3. A total of 31,577 sequence reads passed all quality control steps. We observed a significant increase of Proteobacteria (32,227%) in *db*/*db* mice compared to lean mice (Table [1](#T1){ref-type="table"}). The abundance of 10 genera was significantly affected by the genotype (Table [1](#T1){ref-type="table"}). Interestingly, the genera *Odoribacter, Prevotella*, and *Rikenella* were identified exclusively in the *db*/*db* group, whereas *Enterorhabdus* was identified exclusively in lean mice (Table [1](#T1){ref-type="table"}). Importantly, the abundance of the *Tannerella* genus was increased by approximately 17,112% in *db*/*db* mice. The representatives of the class Deltaproteobacteria and the three genera of the phylum Bacteroidetes, all found exclusively in *db*/*db* mice, are Gram-negative bacteria. Table [A2](#TA2){ref-type="table"} in Appendix shows the significant differences in 96 phylotypes (defined at 97%-ID) enriched or depleted in *db*/*db* mice. Furthermore, the results of the UniFrac analysis (Lozupone et al., [@B41]) clearly showed that *db*/*db* cecal communities were more similar to each other than to the communities of the control lean mice (Figure [1](#F1){ref-type="fig"}A). Principal coordinate analysis (PCoA) of UniFrac-based pairwise comparisons of community structures revealed two clusters corresponding to the two dietary conditions (Figure [1](#F1){ref-type="fig"}B). Importantly, we found a marked positive relationship between the genus *Oscillibacter* and the expression of apelin and APJ (*r* = 0.88, *P* = 0.0006, and *r* = 0.87, *P* = 0.0011, respectively). We also performed deep and global microbiota analysis using the MITChip, a high-throughput phylogenetic microarray designed after the human counterpart (Rajilic-Stojanovic et al., [@B54]), which was previously compared with 454 pyrosequencing (Claesson et al., [@B9]). The profiles of the cecal microbiota were obtained based on the hybridization to over 3,500 oligonucleotide probes and visualized the presence or absence of all targeted operational taxonomic units (OTUs). MITChip analysis revealed a clear separate clustering of the two treatment groups (Figures [2](#F2){ref-type="fig"}C,D) that shared 81.2 (±2.6)% similarities (Pearson product-moment correlation coefficient). We observed a lower relative and absolute abundance of the phyla Bacteroidetes and Deferribacteres in *db*/*db* mice compared to the lean group (Figures [2](#F2){ref-type="fig"}A,B,D), whereas we found a higher abundance of Firmicutes, Proteobacteria, and Fibrobacteres in *db*/*db* mice compared to the lean group (Figures [2](#F2){ref-type="fig"}A,B,D). In accordance with the pyrosequencing analysis, both groups were found to cluster in a genotype-specific manner. In addition to specific changes observed in the pyrosequencing analyses, we found several previously unidentified modifications at a lower taxonomic level, especially the absolute and relative increase of *Prevotella* spp. (not shown).

![**Analysis of gut bacterial communities by 16S rRNA pyrosequencing from obese diabetic mice or lean mice**. **(A)** Clustering of mouse cecal microbial communities in the two tested groups based on unweighted UniFrac analysis and 97%-ID phylotypes. Red indicates the diabetic mice (*db*/*db*), and blue indicates the lean mice. Branch length represents the distance between environments in UniFrac units, indicated by the scale bar (*n* = 5/group). **(B)** PCoA analysis based on unweighted (presence/absence) UniFrac analysis and 97%-ID phylotypes. Each symbol (filled circle or filled square) representing a single sample is colored according to dietary conditions: red corresponds to *db*/*db*, and blue corresponds to lean (*n* = 5/group).](fmicb-02-00149-g001){#F1}

###### 

**Taxa enriched or depleted in *db*/*db* mice**.

  Rank     RDP classification                                                                   Abundance (percent of total sequences)[\*](#tfn1){ref-type="table-fn"}   Change in *db*/*db* group[\*\*](#tfn2){ref-type="table-fn"} (%)   *P* value[\*\*\*](#tfn3){ref-type="table-fn"}   
  -------- ------------------------------------------------------------------------------------ ------------------------------------------------------------------------ ----------------------------------------------------------------- ----------------------------------------------- --------
  Genus    Actinobacteria; Actinobacteria; Coriobacteriales; Coriobacteriaceae; Enterorhabdus   0.019 ± 0.008                                                            0                                                                 LEAN \[3\]                                      0.0449
  Genus    Bacteroidetes; Bacteroidia; Bacteroidales; Porphyromonadaceae; Barnesiella           0.464 ± 0.148                                                            8.204 ± 1.322                                                     1668                                            0.0004
  Genus    Bacteroidetes; Bacteroidia; Bacteroidales; Porphyromonadaceae; Butyricimonas         0.091 ± 0.022                                                            0.006 ± 0.006                                                     −94                                             0.0061
  Genus    Bacteroidetes; Bacteroidia; Bacteroidales; Porphyromonadaceae; Odoribacter           0                                                                        0.150 ± 0.040                                                     DB \[5\]                                        0.0053
  Genus    Bacteroidetes; Bacteroidia; Bacteroidales; Porphyromonadaceae; Parabacteroides       0.756 ± 0.122                                                            0.235 ± 0.070                                                     −69                                             0.0060
  Genus    Bacteroidetes; Bacteroidia; Bacteroidales; Porphyromonadaceae; Tannerella            0.008 ± 0.008                                                            1.346 ± 0.328                                                     17112                                           0.0036
  Family   Bacteroidetes; Bacteroidia; Bacteroidales; Prevotellaceae                            0                                                                        3.590 ± 0.748                                                     DB \[5\]                                        0.0014
  Genus    Bacteroidetes; Bacteroidia; Bacteroidales; Prevotellaceae; Prevotella                0                                                                        2.443 ± 0.463                                                     DB \[5\]                                        0.0008
  Family   Bacteroidetes; Bacteroidia; Bacteroidales; Rikenellaceae                             4.262 ± 0.802                                                            9.061 ± 0.798                                                     113                                             0.0028
  Genus    Bacteroidetes; Bacteroidia; Bacteroidales; Rikenellaceae; Alistipes                  4.262 ± 0.802                                                            9.042 ± 0.794                                                     112                                             0.0029
  Genus    Bacteroidetes; Bacteroidia; Bacteroidales; Rikenellaceae; Rikenella                  0                                                                        0.019 ± 0.008                                                     DB \[3\]                                        0.0409
  Family   Firmicutes; Clostridia; Clostridiales; Ruminococcaceae                               7.259 ± 1.231                                                            14.029 ± 2.216                                                    93                                              0.0283
  Genus    Firmicutes; Clostridia; Clostridiales; Ruminococcaceae; Oscillibacter                5.831 ± 0.858                                                            10.539 ± 1.482                                                    81                                              0.0251
  Phylum   Proteobacteria                                                                       0.006 ± 0.006                                                            2.036 ± 0.570                                                     32227                                           0.0074
  Class    Proteobacteria; Deltaproteobacteria                                                  0                                                                        1.227 ± 0.292                                                     DB \[5\]                                        0.0030

*\*Data are the mean ± SE*.

*\*\*Change in average taxa abundance in db/db mice subset when compared to the lean mice subset. Only changes associated with a P value \< 0.05 are given*.

*\*\*\*P value was determined by a two-tailed Student's t-test with equal variance*.

*\[Number\] following LEAN or DB corresponds to the number of mice in the indicated subset in which the given phylotype was found*.

![**Phylogenetic microarray analysis of gut bacterial communities from obese diabetic mice or lean mice**. **(A)** Percentages of each community contributed by the indicated level 1 bacterial groups. **(B)** PCoA analysis based on MITChip phylogenetic fingerprints of the gut microbiota from the cecal contents of *db*/*db* and lean mice. **(C)** Hierarchical clustering visualizing the similarities of the phylogenetic MITChip fingerprints. Samples were hierarchically clustered based on the Pearson correlation. **(D)** Relative abundance of different bacterial classes expressed as the percentage of total probe signals (*n* = 5/group). \**P* \< 0.05, \*\**P* \< 0.01 determined by a two-tailed Student's *t*-test.](fmicb-02-00149-g002){#F2}

Obese and diabetic mice exhibited a higher endocannabinoid system tone in adipose tissue
----------------------------------------------------------------------------------------

We have previously demonstrated that the gut microbiota contribute to the regulation of eCB system tone in adipose tissue in both physiological and pathological situations (Muccioli et al., [@B50]). In addition, obesity is characterized by higher eCB system tone in both humans and rodents (Engeli et al., [@B24]; Bluher et al., [@B2]; Matias et al., [@B45]; Cote et al., [@B11]; D'Eon et al., [@B16]; Starowicz et al., [@B57]; Izzo et al., [@B34]; Muccioli et al., [@B50]). Consistent with these findings, we discovered that *db*/*db* mice, fed with a standard diet, exhibited an increased eCB system tone (AEA levels and mRNA expression). Anandamide (AEA; Devane et al., [@B17]) is an endogenous CB~1~ and CB~2~ ligand. Here we found a significant increase in AEA levels (about 50%) in adipose tissue (Figure [3](#F3){ref-type="fig"}A). In accordance with this result, NAPE-PLD and CB~1~ mRNA expression were significantly increased, whereas mRNA expression for the AEA-degrading enzyme FAAH was reduced (Figures [3](#F3){ref-type="fig"}B,C,D). Note that expression of monoacylglycerol lipase (MGL), the main enzyme that degrades endocannabinoid 2-arachidonoylglycerol (2-AG), tended to be higher in the adipose tissue of *db*/*db* mice (Figure [3](#F3){ref-type="fig"}E), which is consistent with the reduced 2-AG levels observed in adipose tissue (Figure [3](#F3){ref-type="fig"}F). Altogether, these data demonstrate for the first time that *db*/*db* mice display an altered eCB system tone in adipose tissue, and more specifically, they display increased signaling for the endocannabinoid AEA.

![**Higher endocannabinoid system tone in the adipose tissue of *db*/*db* mice**. **(A)** AEAtissue content (% of lean), **(B)** NAPE-PLD, **(C)** CB~1~, **(D)** FAAH; **(E)** MGL mRNA expression, and **(F)** 2-AG tissue content (% of lean) measured in adipose tissue. Mean ± SEM, *n* = 6/group, \**P* \< 0.05 determined by a two-tailed Student's *t*-test.](fmicb-02-00149-g003){#F3}

Increased apelin and APJ expression in the adipose tissue of obese and diabetic mice
------------------------------------------------------------------------------------

Recent evidence suggests that, in pathophysiological conditions (obesity and type 2 diabetes), the peripheral apelinergic system seems to be deregulated (Dray et al., [@B20], [@B19]; Duparc et al., [@B21]). To date, the mechanisms of regulation of apelin and APJ expression in the adipose tissue of obese and diabetic mice are not fully understood. Therefore, we investigated apelinergic system tone in this model and found that apelin and APJ mRNA levels were significantly increased by two- and three-fold, respectively, in the adipose tissue of *db*/*db* mice compared to lean littermates (Figures [4](#F4){ref-type="fig"}A,B). Plasma apelin was increased by approximately 30%, but did not reach significance (*db*/*db*: 7.1 ± 1, lean: 5.8 ± 0.8 pg/ml).

![**Increased apelin and APJ mRNA expression in the adipose tissue of *db*/*db* mice**. **(A)** Apelin and **(B)** APJ mRNA expression measured in adipose tissue. Mean ± SEM, *n* = 6/group, \**P* \< 0.05 determined by a two-tailed Student's *t*-test.](fmicb-02-00149-g004){#F4}

Interestingly, we found several positive and negative correlations between the abundance of specific bacteria and apelin/APJ expression, suggesting a potential relationship between specific gut bacteria and the regulation of the apelinergic system (Table [2](#T2){ref-type="table"}).

###### 

**Correlations between changes in the abundance of specific bacteria and adipose tissue apelin or APJ mRNA levels**.

                                            *r*     *p*-Value
  ----------------------------------------- ------- -----------
  **Apelin**                                        
  *Acholeplasma et rel*.                    0.73    0.0162
  *Aerococcus urinaeequi et rel*.           0.89    0.0005
  *Atopobium*                               0.70    0.0255
  *Bryantella et rel*.                      0.68    0.0296
  *Butyrivibrio crossotus et rel*.          0.67    0.0344
  *Catenibacterium*                         0.66    0.0364
  *Cl. lactifermentans et rel*.             0.75    0.0120
  *Cl. perfringens et rel*.                 −0.84   0.0024
  *Dialister et rel*.                       0.81    0.0043
  *Eggerthella et rel*.                     −0.65   0.0403
  *Eub. hallii et rel*.                     0.74    0.0135
  *Helicobacter*                            −0.72   0.0181
  *Lachnospira pectinoschiza et rel*.       0.76    0.0110
  *L. salivarius et rel*.                   −0.64   0.0478
  *Mucispirillum schaedleri et rel*.        −0.69   0.0276
  *Porphyromonas asaccharolytica et rel*.   −0.80   0.0057
  *Prevotella*                              −0.68   0.0319
  *R. obeum et rel*.                        0.76    0.0106
  *Sporobacter termitidis et rel*.          0.89    0.0005
  *Unc. Porphyromonadaceae*                 −0.86   0.0016
  **APJ**                                           
  *Acholeplasma et rel*.                    0.74    0.0148
  *Aerococcus urinaeequi et rel*.           0.84    0.0023
  *Atopobium*                               0.68    0.0319
  *Bryantella et rel*.                      0.71    0.0206
  *Butyrivibrio crossotus et rel*.          0.68    0.0321
  *Catenibacterium*                         0.72    0.0197
  *Cl. difficile et rel*.                   0.65    0.0416
  *Cl. lactifermentans et rel*.             0.66    0.0363
  *Cl. perfringens et rel*.                 −0.79   0.0070
  *Dialister et rel*.                       0.79    0.0065
  *Eub. hallii et rel*.                     0.76    0.0116
  *Fibrobacter succinogenes et rel*.        0.65    0.0407
  *Helicobacter*                            −0.76   0.0113
  *Labrys methylaminiphilus et rel*.        0.70    0.0236
  *Lachnospira pectinoschiza et rel*.       0.72    0.0179
  *L. gasseri et rel*.                      0.67    0.0341
  *L. salivarius et rel*.                   −0.67   0.0333
  *Porphyromonas asaccharolytica et rel*.   −0.76   0.0101
  *R. obeum et rel*.                        0.64    0.0479
  *Sporobacter termitidis et rel*.          0.85    0.0017
  *Unc. Porphyromonadaceae*                 −0.86   0.0013

Increased low-grade inflammation in the adipose tissue of db/db mice
--------------------------------------------------------------------

We have previously demonstrated that the higher eCB system tone observed in the adipose tissue of obese and diabetic mice was directly dependent on low-grade inflammatory tone (Muccioli et al., [@B50]). In addition, *db*/*db* mice are considered a widely used model to investigate the metabolic features associated with obesity and type 2 diabetes. These mice are characterized by a low-grade inflammatory tone with higher plasma LPS levels and significantly higher plasma levels of IL-1β, IL-6, TNF-α, and INF-γ (Brun et al., [@B3]). Moreover, the assessment of adipose tissue inflammation revealed an increased number of crown-like structures corresponding to proinflammatory macrophages that are F4/80 and CD11c positive (Mihara et al., [@B48]; Hellmann et al., [@B31]). Consistent with numerous previous reports investigating meta-inflammation in this model, we found a significant increase in both inflammation and macrophage infiltration markers in our *db*/*db* mice. The markers investigated in this study (IL-1, Monocyte Chemoattractant Protein-1 (MCP-1), F4/80, CD11c, and CD68 mRNA expression) were all significantly increased by 50 to 400% in *db*/*db* mice compared to lean mice (Figures [5](#F5){ref-type="fig"}A--E).

![**Increased inflammatory markers in the adipose tissue of *db*/*db* mice**. **(A)** IL-1, **(B)** F4/80, **(C)** MCP-1, **(D)** CD11c, and **(E)** CD68 mRNA expression measured in adipose tissue. Mean ± SEM, *n* = 6/group, \**P* \< 0.05 determined by a two-tailed Student's *t*-test.](fmicb-02-00149-g005){#F5}

Both the eCB system and low-grade inflammation participate in the regulation of adipose tissue apelin and APJ expression
------------------------------------------------------------------------------------------------------------------------

Understanding the molecular mechanisms responsible for the altered apelinergic system is essential to find putative novel targets for modulating adipose tissue metabolism. We have previously shown that both the low-grade inflammatory tone and the higher eCB system tone observed in obesity and related disorders could be linked to gut microbiota composition (Cani et al., [@B8]; Muccioli et al., [@B50]; Cani and Delzenne, [@B7]). More importantly, it has been previously demonstrated that inflammation regulates both apelin and APJ mRNA expression (Daviaud et al., [@B13]; Melgar-Lesmes et al., [@B46]). In addition, our *in vivo* experiments and multiple correlation analyses suggest a link between inflammation and the regulation of the apelinergic system (Figure [A1](#FA1){ref-type="fig"}). However, the causal link between these parameters and the regulation of apelin and APJ expression in the adipose tissue remain to be demonstrated.

Given the difficulty of deciphering the impact of low-grade inflammation (i.e., plasma LPS or cytokines) and eCB system tone on the apelinergic system *in vivo*, we decided to explore these mechanisms on *in vitro* cultured adipose tissue explants. Of note, these explants came from healthy, lean C57BL/6 mice, allowing us to investigate physiological-like or pathological-like situations, that is, eCB system tone modulation with or without a concomitant inflammatory situation.

Here, we found that the activation of the eCB system by a cannabinoid receptor agonist (HU-210) significantly decreased apelin and APJ mRNA expression (Figures [6](#F6){ref-type="fig"}A,B). In line with the results obtained using the cannabinoid receptor agonist *in vitro*, in lean wild-type mice, we found that *in vivo* inhibition of AEA degradation by the administration of a potent FAAH inhibitor (URB597; Kathuria et al., [@B35]) significantly decreased apelin and APJ mRNA expression (Figure [A2](#FA2){ref-type="fig"}). These data support the idea that the eCB system down-regulates the apelinergic system in physiological situations. However, we found that low-dose LPS significantly increased these two markers. More importantly, the adipose tissue explants treated with both cannabinoid receptor agonist and LPS exhibited a significant increase in apelin and APJ mRNA expression (Figures [6](#F6){ref-type="fig"}A,B). Altogether, this set of experiments suggests that both the eCB system and low-grade inflammatory tone contribute to the regulation of apelin and APJ in adipose tissue. Interestingly, concomitant stimulation with eCB agonist and LPS resulted in up-regulation of the apelinergic system. In parallel, we found that two key inflammatory markers (IL-1 and TNF-α) were similarly up-regulated following LPS-eCB treatment (Figures [6](#F6){ref-type="fig"}C,D). These data further confirm that (i) both the eCB system and low-grade inflammation might be overactive during obese and type 2 diabetic situations, and (ii) that LPS and/or inflammation act as a master switch in the regulation of the apelinergic system.

![**The eCB system down-regulates LPS-induced inflammation (IL-1 and TNF-α mRNA expression) and the apelinergic system (apelin and APJ mRNA expression) in adipose tissue explant cultures**. mRNA expression levels of **(A)** Apelin, **(B)** APJ, **(C)** IL-1, and **(D)** TNF-α in cultured adipose tissue explants from lean mice exposed to vehicle (CT), LPS (LPS) or cannabinoid receptor agonist HU-210 (HU; 100 nM) alone or in combination with LPS (100 ng.ml, LPS-HU) for 24 h. \* indicates *P* \< 0.05 for the drug effect; by a two-tailed Student's *t*-test.](fmicb-02-00149-g006){#F6}

Discussion
==========

This study provides new evidence for an altered gut microbiota in type 2 diabetes, independent of fat feeding. Indeed, we demonstrate that the gut microbial community is profoundly impacted by genotype and not necessarily diet because *db*/*db* mice, compared to their littermates, exhibited a profound alteration of the gut microbiota composition. In addition, we found that some taxa are present or rather absent in diabetic mice compared to their lean littermates. These important findings question the potential impact of these bacteria in the onset of the phenotypic alterations characterizing this model. Although the microbiota analysis relied on complementary technologies and classification methods, data showed similar patterns of specific clustering of bacterial communities. We observed a decrease in the abundance of the phylum Bacteroidetes and an increase of Firmicutes. Importantly, we found a dramatic increase of Proteobacteria following the pyrosequencing method. Moreover, ten genera whose abundance was significantly affected by the genotype have been identified. Interestingly, we identified several taxa of Gram-negative bacteria at significantly higher frequencies or exclusively in *db*/*db* mice. Because LPS from Gram-negative bacteria triggered low-grade inflammation and stimulated apelin and APJ expression, we postulate that these specific changes contributed to the phenotype observed in *db*/*db* mice compared to their lean counterparts. In addition to the putative higher content of LPS within the intestinal lumen, it has been previously shown that *db*/*db* mice are characterized by greater intestinal inflammation and gut permeability (Brun et al., [@B3]; Duparc et al., [@B22]). Therefore, in addition to the dysfunction of the leptin action characterizing this mouse model, we propose that the shift in the gut microbial community observed also contributed to the development of the complex phenotype found in *db*/*db* mice. Nevertheless, given the complexity of these modifications and the number of correlations found, the direct association between one or more specific taxa and the changes affecting host physiology remain to be investigated. Hence, further work is required to understand the functional links between the metabolic/catabolic activities of gut bacteria and their impact on host metabolism. For instance, it would be of interest to investigate this genetic model in a germ-free situation to identify the specific impact of the gut microbes on the onset of type 2 diabetes. Importantly, when we compared the classification results from pyrosequencing to those obtained from phylogenetic microarrays, we observed more differences attributed to a deeper analysis of the phylogenetic microarrays (\<0.1% of the community; Rajilic-Stojanovic et al., [@B54]) than pyrosequencing. Recently the impact of use of different primers was assessed by 454 pyrosequencing and could impact the microbial profiling (van den Bogert et al., [@B61]), off note, deep pyrosequencing and phylogenetic microarrays provided similar biological conclusions, although the classification may be different from that in previously reported systems (Claesson et al., [@B9]).

This study also provided novel mechanisms involving the important roles of the eCB and low-grade inflammatory tone in the regulation of one specific adipokine and its receptor, namely, apelin and APJ. Hence, multiple correlation analyses suggest that specific gut microbes positively or negatively correlate with apelin and APJ mRNA. This study also supports the interest of combining high-throughput culture-independent approaches with physiological assessments to define the relationships between gut microbial communities and host metabolism. Nevertheless, given the complexity of these biological systems, the direct association between one or more bacterial groups and the changes affecting host physiology remain to be confirmed.

During the last years, numerous studies have demonstrated a clear relationship between energy metabolism and peripheral apelin action. Under pathophysiological conditions, the peripheral apelinergic system seems to be deregulated (Dray et al., [@B20], [@B19]; Duparc et al., [@B21]). While some researchers found that levels of plasma apelin in humans and mice were increased in obese diabetes (Heinonen et al., [@B30]; Dray et al., [@B20]) and in the insulin resistance state (Soriguer et al., [@B55]), others demonstrated that plasma apelin was reduced in type 2 diabetes patients (Erdem et al., [@B25]). Recently, it has been highlighted that the severity of insulin resistance might influence the regulation of apelin and APJ expression (Dray et al., [@B19]).

In this study, we first demonstrated the presence of an increase in eCB system tone (higher AEA levels, NAPE-PLD, and CB~1~ expression and lower FAAH expression) in the adipose tissue of *db*/*db* mice. Here we show for the first time that AEA levels are increased in adipose tissue and are in accordance with our previous findings (Muccioli et al., [@B50]). In parallel, we found that both apelin and APJ expression were significantly increased. By using multiple correlation analyses, we observed very strong relationships between the eCB system and the apelinergic system, supporting the potential implication of the eCB system in apelinergic tone. However, *db*/*db* mice were also characterized by a higher inflammatory tone (Brun et al., [@B3]), which is, according to our results, positively and significantly correlated with apelin/APJ. Given that *db*/*db* mice also exhibited better eCB system tone and inflammation, we investigated the direct impact of the endocannabinoids. To clarify this issue, we increased endogenous AEA levels in the adipose tissue of lean mice following the inhibition of FAAH (Muccioli et al., [@B50]), the main AEA-degrading enzyme (Muccioli, [@B49]). Strikingly, we found that this procedure significantly decreased apelin and APJ expression. Similarly to these *in vivo* data, the stimulation of adipose tissue explants with cannabinoid agonist profoundly reduced the expression of apelin and APJ. Furthermore, knowing that *db*/*db* mice developed a low-grade inflammatory tone, possibly linked to gut microbiota-derived LPS, we investigated the role of LPS in the regulation of these peptides. Interestingly, we demonstrated that LPS directly increased apelinergic system tone in adipose tissue. We also found that LPS treatment completely counteracted the eCB-dependent down-regulation of apelin and APJ. Taken together, all these data strongly support the concept that both systems are implicated in the regulation of apelinergic tone. However, both our *in vivo* and *in vitro* data point to inflammation as a master control in this cross-talk. Based on these data, we postulate that, in physiological conditions, eCB system tone participates in the down-regulation of the apelinergic system, whereas in pathological conditions, the low-grade inflammatory tone acts as a master switch to increase both eCB system tone and the apelinergic system. Although our data relied on different regulatory mechanisms (eCB tone and metabolic endotoxemia), both are clearly associated with gut microbiota composition (Cani and Delzenne, [@B7]). Thus, understanding the complexity of gut microbiota is increasingly important for deciphering potential interactions between hosts and microbes.

In conclusion, we have demonstrated that the eCB and low-grade inflammatory tone are closely involved in the regulation of apelin and APJ expression in adipose tissue. Moreover, we found that genetic obese and type 2 diabetic mice harbored profound changes in their gut microbiota compositions compared to their lean counterparts. Although we found strong positive and negative relationships between specific bacteria and the apelinergic system, the exact implications of several bacteria for shaping the phenotype of these mice remain to be studied.
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![**Multiple correlation analyses between the apelinergic system and inflammation**. Pairwise correlations between F4/80 or IL-1 and apelin **(A,B)** or APJ **(C,D)** mRNA expression measured in the adipose tissue of *db*/*db* mice. *Insets* in each graph depict Pearson's correlation value of the coefficient (r) and *P* values.](fmicb-02-00149-a001){#FA1}

![**FAAH inhibition decreased Apelin and APJ mRNA expression in the adipose tissue of mice**. Apelin and APJ mRNA expression measured in the adipose tissue of lean mice treated with a single dose of the FAAH inhibitor URB. Mean ± SEM, *n* = 6/group, \**P* \< 0.05 determined by a two-tailed Student's *t*-test.](fmicb-02-00149-a002){#FA2}

###### 

**Sequencing statistics for 10 cecal microbiomes**.

  Primer barcode   Number of filtered sequences   Mouse ID   Group
  ---------------- ------------------------------ ---------- -----------
  692              3470                           1          *db*/*db*
  693              2754                           2          *db*/*db*
  694              3077                           3          *db*/*db*
  695              3038                           4          *db*/*db*
  696              3564                           5          *db*/*db*
  697              2558                           6          lean
  698              3314                           7          lean
  699              2920                           8          lean
  700              3707                           9          lean
  701              3175                           10         lean

*Reverse PCR primers contained barcode sequences described by Hamady et al. ([@B27])*.

###### 

**The 97%-ID phylotypes enriched or depleted in *db/db* mice**.

  Lean[\*](#tfn4){ref-type="table-fn"}   *db/db*[\*\*](#tfn5){ref-type="table-fn"}   Representative sequence   Phylum           Class                 Order              Family               Genus               Change in *db/db* group[\*\*\*](#tfn6){ref-type="table-fn"} (%)   *P-*value
  -------------------------------------- ------------------------------------------- ------------------------- ---------------- --------------------- ------------------ -------------------- ------------------- ----------------------------------------------------------------- -----------
  0.0192 ± 0.0081                        0                                           \>F33FQ7E02I4JJM_129      Actinobacteria   Actinobacteria        Coriobacteriales   Coriobacteriaceae    *Enterorhabdus*     LEAN \[3\]                                                        0.044906
  12.0893 ± 3.5947                       1.8624 ± 0.8334                             \>F33FQ7E01C600C_126      Bacteroidetes    Bacteroidia           Bacteroidales      Bacteroidaceae       *Bacteroides*       −85                                                               0.024243
  0.0068 ± 0.0068                        1.7903 ± 0.4877                             \>F33FQ7E01A2OF5_121      Bacteroidetes    Bacteroidia           Bacteroidales      Bacteroidaceae       *Bacteroides*       26039                                                             0.006437
  0                                      0.4454 ± 0.1490                             \>F33FQ7E01CGOVF_123      Bacteroidetes    Bacteroidia           Bacteroidales      Bacteroidaceae       *Bacteroides*       DB \[5\]                                                          0.017368
  0                                      0.2853 ± 0.0857                             \>F33FQ7E02H3E41_121      Bacteroidetes    Bacteroidia           Bacteroidales      Bacteroidaceae       *Bacteroides*       DB \[5\]                                                          0.010394
  0.2629 ± 0.0783                        0.0332 ± 0.0200                             \>F33FQ7E02I8QUO_122      Bacteroidetes    Bacteroidia           Bacteroidales      Bacteroidaceae       *Bacteroides*       −87                                                               0.021732
  0.0875 ± 0.0340                        0                                           \>F33FQ7E01E3D9N_126      Bacteroidetes    Bacteroidia           Bacteroidales      Bacteroidaceae       *Bacteroides*       LEAN \[4\]                                                        0.032851
  0                                      0.0450 ± 0.0124                             \>F33FQ7E01DXJI5_123      Bacteroidetes    Bacteroidia           Bacteroidales      Bacteroidaceae       *Bacteroides*       DB \[4\]                                                          0.006838
  0                                      3.6365 ± 0.7975                             \>F33FQ7E01A0YO6_121      Bacteroidetes    Bacteroidia           Bacteroidales      Porphyromonadaceae   *Barnesiella*       DB \[5\]                                                          0.001851
  0                                      2.6817 ± 0.6854                             \>F33FQ7E01BBPQI_121      Bacteroidetes    Bacteroidia           Bacteroidales      Porphyromonadaceae   *Barnesiella*       DB \[5\]                                                          0.004465
  0.2900 ± 0.1058                        0.8761 ± 0.2243                             \>F33FQ7E01A6RU1_121      Bacteroidetes    Bacteroidia           Bacteroidales      Porphyromonadaceae   *Barnesiella*       202                                                               0.045730
  0                                      0.3336 ± 0.0743                             \>F33FQ7E01AQUIX_121      Bacteroidetes    Bacteroidia           Bacteroidales      Porphyromonadaceae   *Barnesiella*       DB \[5\]                                                          0.002029
  0                                      0.1618 ± 0.0619                             \>F33FQ7E02JC51O_123      Bacteroidetes    Bacteroidia           Bacteroidales      Porphyromonadaceae   *Barnesiella*       DB \[5\]                                                          0.030955
  0.1166 ± 0.0314                        0.0251 ± 0.0065                             \>F33FQ7E02JY7FW_122      Bacteroidetes    Bacteroidia           Bacteroidales      Porphyromonadaceae   *Barnesiella*       −78                                                               0.021467
  0                                      0.0627 ± 0.0215                             \>F33FQ7E01ESHB2_121      Bacteroidetes    Bacteroidia           Bacteroidales      Porphyromonadaceae   *Barnesiella*       DB \[4\]                                                          0.019226
  0                                      0.0307 ± 0.0090                             \>F33FQ7E01CL9NZ_121      Bacteroidetes    Bacteroidia           Bacteroidales      Porphyromonadaceae   *Barnesiella*       DB \[4\]                                                          0.009230
  0                                      0.0187 ± 0.0077                             \>F33FQ7E02GS3UF_123      Bacteroidetes    Bacteroidia           Bacteroidales      Porphyromonadaceae   *Barnesiella*       DB \[3\]                                                          0.040921
  0.0738 ± 0.0118                        0.0058 ± 0.0058                             \>F33FQ7E02IN2XO_129      Bacteroidetes    Bacteroidia           Bacteroidales      Porphyromonadaceae   *Butyricimonas*     −92                                                               0.000848
  0                                      0.1167 ± 0.0364                             \>F33FQ7E01ALRJX_121      Bacteroidetes    Bacteroidia           Bacteroidales      Porphyromonadaceae   *Odoribacter*       DB \[5\]                                                          0.012401
  0.7043 ± 0.1259                        0.2073 ± 0.0547                             \>F33FQ7E02FWNJN_12 6     Bacteroidetes    Bacteroidia           Bacteroidales      Porphyromonadaceae   *Parabacteroides*   −71                                                               0.006770
  0                                      1.1969 ± 0.2696                             \>F33FQ7E02IVXTK_121      Bacteroidetes    Bacteroidia           Bacteroidales      Porphyromonadaceae   *Tannerella*        DB \[5\]                                                          0.002167
  6.3752 ± 0.8801                        1.2372 ± 0.4627                             \>F33FQ7E01CNJ30_125      Bacteroidetes    Bacteroidia           Bacteroidales      Porphyromonadaceae                       −81                                                               0.000856
  4.6642 ± 0.2789                        1.2713 ± 0.2025                             \>F33FQ7E01E3FCL_129      Bacteroidetes    Bacteroidia           Bacteroidales      Porphyromonadaceae                       −73                                                               0.000010
  5.0688 ± 0.4022                        0.5212 ± 0.0994                             \>F33FQ7E02FZN3W_121      Bacteroidetes    Bacteroidia           Bacteroidales      Porphyromonadaceae                       −90                                                               0.000004
  1.7177 ± 0.1814                        0.2086 ± 0.0710                             \>F33FQ7E02GRXIH_124      Bacteroidetes    Bacteroidia           Bacteroidales      Porphyromonadaceae                       −88                                                               0.000055
  0                                      1.3093 ± 0.1395                             \>F33FQ7E01B29HO_121      Bacteroidetes    Bacteroidia           Bacteroidales      Porphyromonadaceae                       DB \[5\]                                                          0.000014
  0                                      0.6324 ± 0.1115                             \>F33FQ7E01C3L4J_121      Bacteroidetes    Bacteroidia           Bacteroidales      Porphyromonadaceae                       DB \[5\]                                                          0.000469
  0                                      0.1000 ± 0.0100                             \>F33FQ7E02HEYTH_121      Bacteroidetes    Bacteroidia           Bacteroidales      Porphyromonadaceae                       DB \[5\]                                                          0.000008
  4.7315 ± 0.7697                        0.9255 ± 0.2360                             \>F33FQ7E01A18K9_121      Bacteroidetes    Bacteroidia           Bacteroidales      Porphyromonadaceae                       −80                                                               0.001487
  2.2515 ± 0.4312                        0.2271 ± 0.0648                             \>F33FQ7E01ANWA4_128      Bacteroidetes    Bacteroidia           Bacteroidales      Porphyromonadaceae                       −90                                                               0.001661
  0                                      2.1072 ± 0.5609                             \>F33FQ7E01BILQZ_123      Bacteroidetes    Bacteroidia           Bacteroidales      Porphyromonadaceae                       DB \[5\]                                                          0.005567
  0                                      1.3335 ± 0.2954                             \>F33FQ7E01ASH5F_121      Bacteroidetes    Bacteroidia           Bacteroidales      Porphyromonadaceae                       DB \[5\]                                                          0.001964
  0                                      1.0818 ± 0.3838                             \>F33FQ7E01A0TCD_121      Bacteroidetes    Bacteroidia           Bacteroidales      Porphyromonadaceae                       DB \[5\]                                                          0.022548
  0                                      0.9768 ± 0.2686                             \>F33FQ7E01A3Z7I_121      Bacteroidetes    Bacteroidia           Bacteroidales      Porphyromonadaceae                       DB \[5\]                                                          0.006618
  0.4385 ± 0.0257                        0.2444 ± 0.0521                             \>F33FQ7E01EDHYP_121      Bacteroidetes    Bacteroidia           Bacteroidales      Porphyromonadaceae                       −44                                                               0.010208
  0.5135 ± 0.1094                        0.1153 ± 0.0555                             \>F33FQ7E01DHOIX_126      Bacteroidetes    Bacteroidia           Bacteroidales      Porphyromonadaceae                       −78                                                               0.011764
  0                                      0.5304 ± 0.1648                             \>F33FQ7E01BKMLI_121      Bacteroidetes    Bacteroidia           Bacteroidales      Porphyromonadaceae                       DB \[5\]                                                          0.012275
  0                                      0.4636 ± 0.1270                             \>F33FQ7E01CK5EY_121      Bacteroidetes    Bacteroidia           Bacteroidales      Porphyromonadaceae                       DB \[5\]                                                          0.006491
  0.2777 ± 0.0459                        0.0940 ± 0.0334                             \>F33FQ7E01D8VQW_121      Bacteroidetes    Bacteroidia           Bacteroidales      Porphyromonadaceae                       −66                                                               0.011976
  0.2491 ± 0.0575                        0.0559 ± 0.0229                             \>F33FQ7E01DCG2L_129      Bacteroidetes    Bacteroidia           Bacteroidales      Porphyromonadaceae                       −78                                                               0.014184
  0                                      0.3102 ± 0.1254                             \>F33FQ7E01DCCQ5_122      Bacteroidetes    Bacteroidia           Bacteroidales      Porphyromonadaceae                       DB \[5\]                                                          0.038424
  0.1928 ± 0.0376                        0.0305 ± 0.0189                             \>F33FQ7E01ESAZ9_121      Bacteroidetes    Bacteroidia           Bacteroidales      Porphyromonadaceae                       −84                                                               0.004808
  0                                      0.2219 ± 0.0733                             \>F33FQ7E01C8TRS_121      Bacteroidetes    Bacteroidia           Bacteroidales      Porphyromonadaceae                       DB \[5\]                                                          0.016389
  0.1610 ± 0.0267                        0.0370 ± 0.0174                             \>F33FQ7E02JDUL3_123      Bacteroidetes    Bacteroidia           Bacteroidales      Porphyromonadaceae                       −77                                                               0.004563
  0                                      0.1798 ± 0.0502                             \>F33FQ7E01EGUX5_121      Bacteroidetes    Bacteroidia           Bacteroidales      Porphyromonadaceae                       DB \[5\]                                                          0.007194
  0                                      0.1560 ± 0.0425                             \>F33FQ7E02F8ZOW_125      Bacteroidetes    Bacteroidia           Bacteroidales      Porphyromonadaceae                       DB \[5\]                                                          0.006319
  0                                      0.1001 ± 0.0331                             \>F33FQ7E01AKVVR_121      Bacteroidetes    Bacteroidia           Bacteroidales      Porphyromonadaceae                       DB \[5\]                                                          0.016490
  0.0698 ± 0.0219                        0                                           \>F33FQ7E02G9TBG_129      Bacteroidetes    Bacteroidia           Bacteroidales      Porphyromonadaceae                       LEAN \[5\]                                                        0.013009
  0                                      0.0687 ± 0.0222                             \>F33FQ7E02H89Q9_124      Bacteroidetes    Bacteroidia           Bacteroidales      Porphyromonadaceae                       DB \[4\]                                                          0.014827
  0.0724 ± 0.0199                        0                                           \>F33FQ7E01A2NC7_129      Bacteroidetes    Bacteroidia           Bacteroidales      Porphyromonadaceae                       −100                                                              0.006663
  0                                      0.0550 ± 0.0237                             \>F33FQ7E01DZNQX_123      Bacteroidetes    Bacteroidia           Bacteroidales      Porphyromonadaceae                       DB \[4\]                                                          0.049216
  0.0516 ± 0.0079                        0.0066 ± 0.0066                             \>F33FQ7E02FI9M2_127      Bacteroidetes    Bacteroidia           Bacteroidales      Porphyromonadaceae                       −87                                                               0.002383
  0.0522 ± 0.0154                        0                                           \>F33FQ7E01EMBT6_130      Bacteroidetes    Bacteroidia           Bacteroidales      Porphyromonadaceae                       LEAN \[4\]                                                        0.009508
  0                                      0.0302 ± 0.0092                             \>F33FQ7E02GEE19_124      Bacteroidetes    Bacteroidia           Bacteroidales      Porphyromonadaceae                       DB \[4\]                                                          0.010932
  0.0192 ± 0.0081                        0                                           \>F33FQ7E02IRC4P_129      Bacteroidetes    Bacteroidia           Bacteroidales      Porphyromonadaceae                       LEAN \[3\]                                                        0.044906
  0.0185 ± 0.0077                        0                                           \>F33FQ7E02FIWV8_128      Bacteroidetes    Bacteroidia           Bacteroidales      Porphyromonadaceae                       LEAN \[3\]                                                        0.041773
  0                                      2.3778 ± 0.4610                             \>F33FQ7E02FKEY5_121      Bacteroidetes    Bacteroidia           Bacteroidales      Prevotellaceae       *Prevotella*        DB \[5\]                                                          0.000866
  0                                      0.0327 ± 0.0105                             \>F33FQ7E01DGOVW_121      Bacteroidetes    Bacteroidia           Bacteroidales      Prevotellaceae       *Prevotella*        DB \[4\]                                                          0.014218
  0                                      0.0203 ± 0.0083                             \>F33FQ7E01C3YFS_124      Bacteroidetes    Bacteroidia           Bacteroidales      Prevotellaceae       *Prevotella*        DB \[3\]                                                          0.040453
  0                                      0.9523 ± 0.3752                             \>F33FQ7E01A2XH5_121      Bacteroidetes    Bacteroidia           Bacteroidales      Prevotellaceae                           DB \[4\]                                                          0.034809
  1.8525 ± 0.1536                        0.9054 ± 0.0629                             \>F33FQ7E02I2HAW_125      Bacteroidetes    Bacteroidia           Bacteroidales      Rikenellaceae        *Alistipes*         −51                                                               0.000451
  0                                      2.0120 ± 0.3326                             \>F33FQ7E01B7G3N_122      Bacteroidetes    Bacteroidia           Bacteroidales      Rikenellaceae        *Alistipes*         DB \[5\]                                                          0.000306
  0                                      1.2598 ± 0.1877                             \>F33FQ7E01ECJMT_121      Bacteroidetes    Bacteroidia           Bacteroidales      Rikenellaceae        *Alistipes*         DB \[5\]                                                          0.000151
  0                                      0.3096 ± 0.0239                             \>F33FQ7E01D10PO_121      Bacteroidetes    Bacteroidia           Bacteroidales      Rikenellaceae        *Alistipes*         DB \[5\]                                                          0.000001
  0                                      0.0438 ± 0.0071                             \>F33FQ7E02HM2Q2_121      Bacteroidetes    Bacteroidia           Bacteroidales      Rikenellaceae        *Alistipes*         DB \[5\]                                                          0.000260
  0                                      0.9561 ± 0.2985                             \>F33FQ7E01DV3E4_125      Bacteroidetes    Bacteroidia           Bacteroidales      Rikenellaceae        *Alistipes*         DB \[5\]                                                          0.012559
  0.0192 ± 0.0081                        04489 ± 0.0977                              \>F33FQ7E01BPSG1_121      Bacteroidetes    Bacteroidia           Bacteroidales      Rikenellaceae        *Alistipes*         2232                                                              0.002335
  0                                      0.1718 ± 0.0358                             \>F33FQ7E02HL6E5_121      Bacteroidetes    Bacteroidia           Bacteroidales      Rikenellaceae        *Alistipes*         DB \[5\]                                                          0.001354
  0                                      0.1270 ± 0.0356                             \>F33FQ7E02FW8RL_123      Bacteroidetes    Bacteroidia           Bacteroidales      Rikenellaceae        *Alistipes*         DB \[4\]                                                          0.007337
  0                                      0.0971 ± 0.0284                             \>F33FQ7E01CI251_124      Bacteroidetes    Bacteroidia           Bacteroidales      Rikenellaceae        *Alistipes*         DB \[5\]                                                          0.009102
  0                                      0.0627 ± 0.0198                             \>F33FQ7E01BPHML_121      Bacteroidetes    Bacteroidia           Bacteroidales      Rikenellaceae        *Alistipes*         DB \[5\]                                                          0.013358
  0.1365 ± 0.0202                        0.0121 ± 0.0074                             \>F33FQ7E01D8XEK_128      Bacteroidetes    Bacteroidia           Bacteroidales                                               −91                                                               0.000415
  11.4169 ± 1.5069                       3.6840 ± 1.3411                             \>F33FQ7E02G32BC_122      Bacteroidetes    Bacteroidia           Bacteroidales                                               −68                                                               0.004994
  1.4719 ± 0.1867                        0.3390 ± 0.1286                             \>F33FQ7E02I8FKV_127      Bacteroidetes    Bacteroidia           Bacteroidales                                               −77                                                               0.001058
  0                                      1.2048 ± 04604                              \>F33FQ7E01AQVVG_121      Bacteroidetes    Bacteroidia           Bacteroidales                                               DB \[5\]                                                          0.030802
  0                                      0.0978 ± 0.0205                             \>F33FQ7E01D7P9O_124      Bacteroidetes    Bacteroidia           Bacteroidales                                               DB \[5\]                                                          0.001401
  0                                      0.0834 ± 0.0345                             \>F33FQ7E02GLPUM_123      Bacteroidetes    Bacteroidia           Bacteroidales                                               DB \[4\]                                                          0.041894
  0                                      0.0520 ± 0.0152                             \>F33FQ7E01AZMCB_121      Bacteroidetes    Bacteroidia           Bacteroidales                                               DB \[5\]                                                          0.008918
  0.0551 ± 0.0181                        0.0058 ± 0.0058                             \>F33FQ7E01DIWOC_128      Bacteroidetes                                                                                      −90                                                               0.031791
  0.0480 ± 0.0174                        0.0056 ± 0.0056                             \>F33FQ7E02H64OA_130      Bacteroidetes                                                                                      −88                                                               0.048434
  0.0729 ± 0.0549                        1.3321 ± 0.3500                             \>F33FQ7E01DDMOM_121      Firmicutes       Bacilli               Lactobacillales    Lactobacillaceae     *Lactobacillus*     1728                                                              0.007464
  0.6410 ± 0.1434                        0.0534 ± 0.0378                             \>F33FQ7E02GQQO9_121      Firmicutes       Bacilli               Lactobacillales    Lactobacillaceae     *Lactobacillus*     −92                                                               0.004156
  0.3824 ± 0.1115                        0.0640 ± 0.0192                             \>F33FQ7E01EC512_127      Firmicutes       Clostridia            Clostridiales      Lachnospiraceae                          −83                                                               0.022693
  0                                      0.2492 ± 0.0886                             \>F33FQ7E01DMCSH_121      Firmicutes       Clostridia            Clostridiales      Lachnospiraceae                          DB \[5\]                                                          0.022742
  0.0549 ± 0.0144                        0.0065 ± 0.0065                             \>F33FQ7E02HWP6Z_123      Firmicutes       Clostridia            Clostridiales      Lachnospiraceae                          −88                                                               0.015639
  0.0614 ± 0.0262                        0                                           \>F33FQ7E02GZ92D_130      Firmicutes       Clostridia            Clostridiales      Lachnospiraceae                          LEAN \[3\]                                                        0.047037
  0.0368 ± 0.0117                        0                                           \>F33FQ7E02H234E_129      Firmicutes       Clostridia            Clostridiales      Lachnospiraceae                          LEAN \[4\]                                                        0.013502
  0                                      0.0180 ± 0.0074                             \>F33FQ7E02GU66L_121      Firmicutes       Clostridia            Clostridiales      Lachnospiraceae                          DB \[3\]                                                          0.040941
  1.4801 ± 0.2784                        4.5705 ± 1.1523                             \>F33FQ7E01A2P5 Q_121     Firmicutes       Clostridia            Clostridiales      Ruminococcaceae      *Oscillibacter*     209                                                               0.031277
  0.0129 ± 0.0079                        0.3393 ± 0.0881                             \>F33FQ7E01A0MY3_121      Firmicutes       Clostridia            Clostridiales      Ruminococcaceae      *Oscillibacter*     2533                                                              0.006123
  0.0530 ± 0.0168                        0.2026 ± 0.0618                             \>F33FQ7E01DZQUH_125      Firmicutes       Clostridia            Clostridiales      Ruminococcaceae      *Oscillibacter*     282                                                               0.047669
  0                                      0.2003 ± 0.0687                             \>F33FQ7E02GQMSD_123      Firmicutes       Clostridia            Clostridiales      Ruminococcaceae                          DB \[4\]                                                          0.019376
  0                                      0.0830 ± 0.0206                             \>F33FQ7E01CWU7L_122      Firmicutes       Clostridia            Clostridiales                                               DB \[5\]                                                          0.003790
  0                                      1.1947 ± 0.2830                             \>F33FQ7E01AOJ8E_121      Proteobacteria   Deltaproteobacteria                                                               DB \[5\]                                                          0.002912
  0                                      0.1342 ± 0.0254                             \>F33FQ7E01C4Q69_123      Proteobacteria                                                                                     DB \[5\]                                                          0.000751
  0                                      0.9103 ± 0.3114                             \>F33FQ7E01DFMOY_123                                                                                                         DB \[5\]                                                          0.019191

*\*Data are the mean ± SE*.

*\*\*Change in average relative 97%-ID phylotype abundance in the *db/db* mice subset when compared to the lean mice subset*.

*\*\*\*Only significant (*P* \< 0.05) differences between the two groups are indicated. *P*-values are based on the two-sample *t*-test assuming equal variances. DB, phylotypes found only in prebiotic-fed mice; LEAN, phylotypes found only in the lean group; \[number\] following DB or LEAN corresponds to the number of samples in the subset in which the given phylotype was found*.
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